PCO patients will be assessed clinically,urine \& blood samples will be tested. Systolic \& diastolic blood pressure, serum glucose \& insulin levels, lipid profile, C-reactive protein, complete hormonal profile, and Urinary albumin excretion will be measured.
PCO patients with 2 of 3 criteria: oligo- or anovulation ; hyperandrogenism \&polycystic ovaries. Exclusion criteria: pregnancy, diabetes, hypertension , adrenal \& thyroid dysfunction. Blood samples after overnight fast (8hrs) at day 2 or 3 of menstrual cycle. Serum concentration of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, total testosterone \& sex hormone binding globulin, serum 17-hydroxy (OH) progesterone \& dehydroepiandrosterone sulfate will be measured. Oral glucose tolerance test \& plasma insulin levels will be measured. Total cholesterol, triglycerides, high\& low density lipoproteins. Urinary albumin will be measured\& all the data will be analysed.
Study Type
OBSERVATIONAL
Enrollment
50
Number of patients with hyperinsulinemia (uIU/ml)
Time frame: 3 months
Number of patients with hyperlipidemia (mg/dl).
Time frame: 3 months
Number of patients with albuminuria(ug/ml)
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.